XML 17 R6.htm IDEA: XBRL DOCUMENT v3.20.2
Condensed Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($)
Common Stock
Additional paid-in capital
Retained earnings
Accumulative other comprehensive income
Non-controlling interests
Total
Balance at Dec. 31, 2018 $ 31,017 $ 105,737,256 $ (188,085,680) $ (8,961,549) $ 4,601,121 $ (86,667,836)
Balance (in Shares) at Dec. 31, 2018 31,017,083          
Net income (loss) (1,328,656) (350,142) (1,678,798) [1]
Foreign currency translation adjustment 9,598,800 (915,945) (8,682,855)
Balance at Mar. 31, 2019 $ 31,017 115,336,056 (189,414,336) (9,877,494) (4,250,979) (79,673,778)
Balance (in Shares) at Mar. 31, 2019 31,017,083          
Balance at Dec. 31, 2019 $ 33,810 107,825,827 (213,314,612) 12,989,408 4,361,361 (88,077,205)
Balance (in Shares) at Dec. 31, 2019 33,810,416          
Issuance of common stocks for conversion of debts $ 580 434,420 435,000
Issuance of common stocks for conversion of debts (in Shares) 579,999          
Net income (loss) 117,206,758 (62) 117,206,696
Share-based payments $ 3,750 1,187,250 1,191,000
Share-based payments (in Shares) 3,750,000          
Foreign currency translation adjustment 1,542,682 (2,139,117) (596,435)
Disposal of discontinued operation 10,781,209 (4,311,127) (15,092,236)
Balance at Mar. 31, 2020 $ 38,140 $ 109,474,497 $ (96,107,854) $ 3,750,881 $ (2,088,945) $ 15,066,719
Balance (in Shares) at Mar. 31, 2020 38,140,415          
[1] Reclassification- certain reclassifications have been made to the financial statements for the period ending March 31, 2019 to conform to the presentation for the period ending March 31, 2020, with no effect on previously reported net income (loss).